Galaxy receives CE mark for brain aneurysm systemGalaxy Therapeutics Inc. received CE mark approval under the European Medical Device Regulation for its SEAL embolization system, which is designed for the treatment of ruptured and unruptured wide-neck intracranial aneurysms. The company believes that the device can simplify aneurysm treatment while addressing a broad range of complex anatomies and offers physicians an alternative option for wide neck bifurcation aneurysms.